1 - 20 of about 101
English: Wada N, Ishikawa M, Nagabuchi M, Makino S, Miyauchi K, Abe N, Kakizaki H., Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder. , Int J Urology Case Reports , vol.5 (p.384 - 388) , 2022
English: Yoshida M, Gotoh M, Yokoyama O, Kakizaki H, Yamanishi T, Yamaguchi O., Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study. , World Journal of Urology , vol.40 (11) (p.2799 - 2805) , 2022
English: Wada N, Abe N, Miyauchi K, Ishikawa M, Makino S, Kakizaki H., Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis. , Int Urol Nephrol , vol.54 (6) (p.1193 - 1198) , 2022
English: Takeda T, Shonaka T, Tani C, Hayashi T, Kakizaki H, Sumi Y., Gracilis muscle flap combined with a laparoscopic transabdominal approach is effective in the treatment of post-prostatectomy rectourethral fistula: A case report. , Int J Surgery Case Reports , vol.92 , 2022
English: Wada N, Abe N, Miyauchi K, Ishikawa M, Kakizaki H., Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement. , Int Urol Nephrol , vol.54 (1) (p.3 - 36) , 2022
English: Wada N, Watanabe M, Ishikawa M, Takeuchi K, Miyauchi K, Abe N, Banjo H, Kita M, Kakizaki H., Uroflowmetry pattern in detrusor underactivity and bladder outlet obstruction in male patients with lower urinary tract symptoms. , Lower Urinary Tract Symptoms , 2021
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K., Cardiovascular safety of vibegron, a new β3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. , Neurourology and Urodynamics , vol.40 (6) (p.1651 - 1660) , 2021
English: Katoh T, Kakizaki H, Lee KS, et al, Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post-hoc analysis from the MATCH study. , Lower Urinary Tract Symptoms , vol.13 (1) (p.98 - 107) , 2021
English: Kakizaki H, Lee KS, Katou D, Yamamoto O, Sumarsono B, Uno S, Yamaguchi O., Mirabegron add-on therapy to tamsulosin in men with overactive bladder: Post hoc analyses of efficacy from the MATCH study. , Advances in Therapy , 2020
English: Fukudo M, Tamaki G, Azumi M, Kakizaki H, Tasaki Y., Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma. , Investigational New Drugs , 2020
English: Kakizaki H, Wada N, Watanabe M, Kita M, Hori J, Tamaki G., Managing sphincter deficiency stress urinary incontinence in the neurogenic patients: Diagnosis and management strategies. , Current Bladder Dusfunction Reports , 2020
English: Katoh T, Kakizaki H, Lee KS, Ishida K, Katou D, Yamamoto O, Jong JJ, Sumarsono B, Uno S, Yamaguchi O., Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactivebladder in men with lower urinary tract symptoms: A post-hoc analysis from the MATCH study. , Lower Urinary Tract Symptoms , 2020
English: Wada N, Yoshimura N, Kurobe M, Saito T, Tyagi P, Kakizaki H., The early, long-term inhibition of brain-derived neurotrophic factor improves voidings and storage dysfunctions in mice with spinal cord injury. , Neurourology and urodynamics , vol.39 (5) (p.1345 - 1354) , 2020
English: Wada N, Kikuchi D, Tateoka J, Abe N, Watanabe M, Tamaki G, Kita M, Kakizaki H., Persistence rate with tadalafil for treatment of male lower urinary tract symptoms. , Urol Int , vol.29 (4) (p.1 - 5) , 2020
English: Sekido N, Igawa Y, Kakizaki H, Kitta T, Sengoku A, Takahashi S, Takahashi R, Tanaka K, Namima T, Honda M, Mitsui T, Yamanishi T,Watanabe T., Clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord injury , International Journal of Urology , 2020
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K., Efficacy of vibegron, a novel β3-adrenoceptor agonist, on severe urgency urinary incontinence related to overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. , British Journal of Urology International , 2020
English: Wada N, Kikuchi D, Tateoka J, Abe N, Banjo H, Tsuchida M, Hori J, Tamaki G, Kita M, Kakizaki H., Long-term symptomatic outcome after transurethral resection of the prostate: A urodynamic-based assessment. , International Journal of Urology , vol.26 (11) (p.1071 - 1075) , 2019
English: Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A and Kuroishi K., Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to miranegron monotherapy: A multicenter, randomozed study in Japan (MILAI II study) , International Journal of Urology , vol.26 (3) (p.342 - 352) , 2019
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Hashimoto K and Minemura K.:, Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study. , International Journal of Urology , vol.26 (3) (p.369 - 375) , 2019
English: Rosier PFW, Kuo HC, De Gennaro M, Gammie A, Agro EF, Kakizaki H,Hashim H, Toozs-Hobson P., International Consultation on Incontinence 2016; Executive summary: Urodynamic testing. , Neurourology and urodynamics , vol.38 (2) (p.545 - 552) , 2019
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.